Related Experiment Video
Updated: Feb 1, 2026

Author Spotlight: Identifying Compensatory Pathways in Malaria Parasites Containing Hypomorphic Allele of Essential Protein Kinases
Published on: November 22, 2024
Pharmacogenetic tools for malaria and TB in the Developing World
Pedro Eduardo Ferreira1,2, Isa Cavaco2,3, José Pedro Gil1,2
1Malaria Research, Department of Medicine, Karolinska Institutet, Rätzius väg 10, plan 5, 171 77 Stockholm, Sweden. jose.pedro.gil@ki.se.
Personalized medicine using pharmacogenetics for malaria and TB is promising. Polymorphic genes for amodiaquine and isoniazid metabolism offer potential for safer drug use in developing nations.
Area of Science:
- Pharmacogenetics
- Infectious Diseases
- Drug Metabolism
Background:
- Malaria and TB treatments involve high drug exposures, with amodiaquine and isoniazid being key drugs.
- Both amodiaquine and isoniazid are linked to severe adverse events.
- These drugs undergo polymorphic metabolism via CYP2C8 and N-acetyltransferase 2, respectively.
Purpose of the Study:
- To review the rationale for using pharmacogenetics in malaria and TB treatment.
- To assess the feasibility of applying pharmacogenetic-based personalized medicine in developing countries for these diseases.
Main Methods:
- Review of existing literature on amodiaquine and isoniazid metabolism.
- Analysis of genetic polymorphisms in CYP2C8 and N-acetyltransferase 2.
- Evaluation of the potential for personalized medicine in resource-limited settings.
Main Results:
- CYP2C8 and N-acetyltransferase 2 genetic polymorphisms are strong candidates for pharmacogenetic applications.
- The polymorphic nature of these enzymes impacts drug efficacy and safety.
- Current infrastructure and accessibility in developing nations pose challenges for implementation.
Conclusions:
- Pharmacogenetics holds significant potential for optimizing malaria and TB treatment safety and efficacy.
- Implementing personalized medicine for these diseases in developing countries requires addressing logistical and economic barriers.
- Further research and infrastructure development are crucial for successful pharmacogenetic integration.
Related Concept Videos
Sustainable Development
Development of the Lymphatic System
The first lymph sacs to form are the paired jugular lymph sacs located at the junction of the internal jugular and subclavian veins. From these sacs, lymphatic capillary plexuses extend to the thorax, upper limbs, neck, and head, eventually forming lymphatic vessels. Each jugular lymph sac maintains a...
Language Development
The critical period for language acquisition suggests that the ability to acquire language is at its peak early in life. As people age, this proficiency decreases. Language development begins very...
Overview of Microsoft Excel as a Data Analysis Tool
Development of Immunocompetence
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
Development of the Heart
As the embryo undergoes lateral folding, these paired tubes approach each other, merging into a single primitive heart...

